Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
Original Study

Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey

James K. Stoller, MD, Peter Smith, Peter Yang, MS and Judy Spray, PhD
Cleveland Clinic Journal of Medicine November 1994, 61 (6) 461-467;
James K. Stoller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judy Spray
Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation (J.K.S.), the Alpha-1 National Association (J.K.S., P.S., J.S.), and ACT (American College Testing) (P.Y., J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

BACKGROUND Emphysema associated with alpha 1-antitryp sin deficiency can impose serious impairment.

OBJECTIVE To gather information about the impact of severe alpha 1-antitrypsin deficiency.

METHODS Mail survey, descriptive statistics.

RESULTS We sent a survey to 1730 subscribers to a national newsletter, 850 of whom had previously stated they had alpha 1-antitrypsin deficiency. A total of 414 questionnaires were returned; 398 respondents said they had alpha 1-antitrypsin deficiency, and 300 said they had the PiZZ phenotype. Sixty-six respondents who said they had the disease did not know their phenotype. Among the 304 respondents with severe deficiency, the mean age at the time symptoms first appeared was 35.0 years, but the mean age when the disease was diagnosed was 41.3 years. Overall, 75.3% of respondents with severe deficiency reported at least one adverse effect: 44-4% retired early, and 19.1% changed to a physically easier job. The duration of diagnostic delay correlated with the degree of adverse psychosocial effects.

CONCLUSIONS Alpha 1-antitrypsin deficiency frequently escapes diagnosis despite many medical encounters. Affected individuals are often unaware of basic details of their disease. Many patients report adverse psychosocial effects. Delay in diagnosing this disease is associated with adverse psychosocial effects.

INDEX TERMS
  • ALPHA 1-ANTITRYPSIN
  • QUALITY OF LIFE
  • QUESTIONNAIRES
  • SELF-HELP GROUPS
  • Copyright © 1994 The Cleveland Clinic Foundation. All Rights Reserved.
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 61 (6)
Cleveland Clinic Journal of Medicine
Vol. 61, Issue 6
1 Nov 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey
James K. Stoller, Peter Smith, Peter Yang, Judy Spray
Cleveland Clinic Journal of Medicine Nov 1994, 61 (6) 461-467;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey
James K. Stoller, Peter Smith, Peter Yang, Judy Spray
Cleveland Clinic Journal of Medicine Nov 1994, 61 (6) 461-467;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Impact of Delayed Diagnosis of Alpha-1 Antitrypsin Deficiency: The Association Between Diagnostic Delay and Worsened Clinical Status
  • Hidden burden of osteoporosis in alpha-1 antitrypsin deficiency
  • Alpha-1 antitrypsin deficiency: An underrecognized, treatable cause of COPD
  • Detection of Alpha-1 Antitrypsin Deficiency by Respiratory Therapists: Experience With an Educational Program
  • Knowledge of Alpha-1 Antitrypsin Deficiency Among Internal Medicine House Officers and Respiratory Therapists: Results of a Survey
  • {alpha}1-Antitrypsin deficiency: best clinical practice
  • Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency
  • {alpha}1-Antitrypsin deficiency * 3: Clinical manifestations and natural history
  • {alpha}1-Antitrypsin deficiency
  • Respiratory symptoms and lung function in young adults with severe {alpha}1-antitrypsin deficiency (PiZZ)
  • Clinical features and prognosis of life time non-smokers with severe alpha 1-antitrypsin deficiency
  • Google Scholar

More in this TOC Section

  • Multidisciplinary treatment for chronic low back pain: a randomized, prospective study
  • Radical hysterectomy for cervical cancer: the effect of shorter length of stay on outcome
Show more Original Study

Similar Articles

Keywords

  • ALPHA 1-ANTITRYPSIN
  • QUALITY OF LIFE
  • QUESTIONNAIRES
  • Self-help groups

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire